{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:48Z","timestamp":1791357288663,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1124\/mol.117.108563","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:35:15Z","timestamp":1492734915000},"page":"88-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye"],"prefix":"10.1016","volume":"92","author":[{"given":"Atefeh Mousavi","family":"Nik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Pressly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Antrobus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hulsizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rogawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac N.","family":"Pessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.117.108563_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1460-9568.1998.00038.x","article-title":"Block by picrotoxin of a GABAergic chloride channel expressed on crayfish muscle after axotomy","volume":"10","author":"Adelsberger","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.117.108563_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(04)62001-0","article-title":"GABAA receptor structure-function studies: a reexamination in light of new acetylcholine receptor structures","volume":"62","author":"Akabas","year":"2004","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/mol.117.108563_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2007.03.004","article-title":"Mechanisms of neurosteroid interactions with GABAA receptors","volume":"116","author":"Akk","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.117.108563_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsbmb.2015.07.012","article-title":"\u03b23 homopentameric GABAA receptor","volume":"154","author":"Alvarez","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/mol.117.108563_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"\u03b3-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.117.108563_bib6","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/mol.117.108563_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABAA receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/mol.117.108563_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pharmthera.2006.03.006","article-title":"Molecular diversity, trafficking and subcellular localization of GABAB receptors","volume":"110","author":"Bettler","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.117.108563_bib9","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABAA receptor channels from low- to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/mol.117.108563_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/mol.117.108563_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","article-title":"The GABAA receptor as a therapeutic target for neurodevelopmental disorders","volume":"86","author":"Braat","year":"2015","journal-title":"Neuron"},{"key":"10.1124\/mol.117.108563_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABAA receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/mol.117.108563_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Reviews","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.117.108563_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"\u03b14\u03b23\u03b4 GABAA receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.117.108563_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jmgm.2006.06.001","article-title":"Molecular modelling of the GABAA ion channel protein","volume":"25","author":"Campagna-Slater","year":"2007","journal-title":"J Mol Graph Model"},{"key":"10.1124\/mol.117.108563_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/toxsci\/kfs244","article-title":"Tetramethylenedisulfotetramine alters Ca2+ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABAA receptor-positive modulation","volume":"130","author":"Cao","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1124\/mol.117.108563_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one), a selective, high-affinity, steroid modulator of the \u03b3-aminobutyric acidA receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.117.108563_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pestbp.2014.11.006","article-title":"Novel GABA receptor pesticide targets","volume":"121","author":"Casida","year":"2015","journal-title":"Pestic Biochem Physiol"},{"key":"10.1124\/mol.117.108563_bib18","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1073\/pnas.0600370103","article-title":"\u03b3-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.108563_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/mol.112.078410","article-title":"\u03b23 subunit of the GABAA receptor","volume":"82","author":"Chen","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.117.108563_bib20","unstructured":"Covey DF and Jiang X (2014) inventors, Washington University, assignee. Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally related pentacylic steroids. U.S. Patent 8,759,330. 2014 Jun 24."},{"key":"10.1124\/mol.117.108563_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-0270(85)90068-8","article-title":"A new method of monitoring membrane potential in rat hippocampal slices using cyanine voltage-sensitive dyes","volume":"13","author":"Dasheiff","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1124\/mol.117.108563_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058260","article-title":"Membrane potential measurements of isolated neurons using a voltage-sensitive dye","volume":"8","author":"Fairless","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.117.108563_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2007.03.007","article-title":"Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors","volume":"116","author":"Herd","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.117.108563_bib24","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1007\/s00213-014-3494-5","article-title":"Pharmacological profile of a 17\u03b2-heteroaryl-substituted neuroactive steroid","volume":"231","author":"Hogenkamp","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.117.108563_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABAA receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.117.108563_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1087057108315036","article-title":"Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABAA receptor","volume":"13","author":"Joesch","year":"2008","journal-title":"J Biomol Screen"},{"key":"10.1124\/mol.117.108563_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"\u03b3-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 8","key":"10.1124\/mol.117.108563_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12025","article-title":"How theories evolved concerning the mechanism of action of barbiturates","volume":"53","author":"L\u00f6scher","year":"2012","journal-title":"Epilepsia"},{"key":"10.1124\/mol.117.108563_bib29","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.bjp.0703259","article-title":"Allosteric modulators affect the efficacy of partial agonists for recombinant GABAA receptors","volume":"129","author":"Maksay","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.117.108563_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/mol.106.028597","article-title":"Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating","volume":"71","author":"McCartney","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.117.108563_bib31","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1523\/JNEUROSCI.5607-09.2010","article-title":"Diverse voltage-sensitive dyes modulate GABAA receptor function","volume":"30","author":"Mennerick","year":"2010","journal-title":"J Neurosci"},{"key":"10.1124\/mol.117.108563_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature13293","article-title":"Crystal structure of a human GABAA receptor","volume":"512","author":"Miller","year":"2014","journal-title":"Nature"},{"key":"10.1124\/mol.117.108563_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2012.00001","article-title":"GABA potency at GABAA receptors found in synaptic and extrasynaptic zones","volume":"6","author":"Mortensen","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/mol.117.108563_bib34","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1073\/pnas.0601121103","article-title":"Picrotoxin-like channel blockers of GABAA receptors","volume":"103","author":"Olsen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.108563_bib35","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","article-title":"Neurosteroids\u2014endogenous regulators of seizure susceptibility and role in the treatment of epilepsy","author":"Reddy","year":"2012"},{"key":"10.1124\/mol.117.108563_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/jphysiol.1996.sp021784","article-title":"Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons","volume":"497","author":"Rho","year":"1996","journal-title":"J Physiol"},{"key":"10.1124\/mol.117.108563_bib37","first-page":"613","article-title":"Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer\u2019s disease","volume":"117","author":"Rissman","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/mol.117.108563_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.117.108563_bib41","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","article-title":"Pathophysiology of epilepsy in autism spectrum disorders","author":"Stafstrom","year":"2012"},{"key":"10.1124\/mol.117.108563_bib42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1113\/jphysiol.2001.012818","article-title":"Modulation of GABAA receptor channel gating by pentobarbital","volume":"537","author":"Steinbach","year":"2001","journal-title":"J Physiol"},{"key":"10.1124\/mol.117.108563_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.117.108563_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2011.00044","article-title":"Neurosteroids and GABA-A Receptor Function","volume":"2","author":"Wang","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/mol.117.108563_bib45","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1460-9568.1997.tb01641.x","article-title":"\u03b23 GABAA receptors","volume":"9","author":"Wooltorton","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.117.108563_bib46","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1073\/pnas.1407379111","article-title":"GABAA receptor target of tetramethylenedisulfotetramine","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24006552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24006552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.117.108563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:21:01Z","timestamp":1739960461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24006552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0026895X24006552"],"URL":"https:\/\/doi.org\/10.1124\/mol.117.108563","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.117.108563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}